Oxford University Innovation (OUI) returned to San Francisco on Tuesday 13 January 2026 to host its third annual ‘Investing in Oxford’ event during the J.P. Morgan Healthcare Conference week. Bringing together international investors, corporates and Oxford spinouts, the evening highlighted why Oxford remains one of the world’s most compelling places to invest in life sciences innovation.
ImpactU has received €300,000 from Financière de Tubize to expand its support for university-linked social ventures developing sustainable health solutions in low-resource regions.
A gathering of investors and life sciences ventures from Oxford and Cambridge showcased the region’s research strengths and its growing impact on global health.
For 25 years, Oxford’s University Challenge Seed Fund has helped to create almost 100 companies
Oxford Ionics has been acquired by US-listed IonQ in a landmark $1.075 billion deal - the largest quantum acquisition to emerge from the University of Oxford to date.
Oxford University Innovation spinout OrganOx is set to be acquired by Terumo Corporation in a landmark $1.5 billion deal. The agreement marks the largest acquisition of an Oxford spinout to date and highlights the strength of OUI’s spinout model, which has supported OrganOx from its inception in 2008 through to its position today as a leader in advanced organ preservation.
From biotech to quantum and AI-driven music tech, this year’s StEP Ignite cohort proved that Oxford’s next generation of innovators are building bold solutions for real-world challenges.
OrganOx, a spinout from the University of Oxford formed with support from Oxford University Innovation, has been awarded the UK’s most prestigious engineering prize for its organ preservation technology that is transforming transplant outcomes worldwide.
Thelior Bio working on new class of therapies
Celebrating student ingenuity with real-world purpose, the 2025 Jamie Ferguson Innovation Awards spotlighted Oxford’s next generation of problem-solvers - recognising research that not only breaks scientific ground but aims to change lives.
